Company / EPS (Diluted)
Xencor Inc EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.20
FY2025
5-year range
-$2.20 / $1.37
FY2021-FY2025
Trend
-136.6%
vs FY2024
Sector context
#133 of 204
Health Care
What the data says
At $-2.20, Xencor Inc's eps (diluted) ranks #133 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-2.20 in FY2025 to $1.37 in FY2023.
Based on SEC 10-K filings.
-2.20 in FY2025.
Declined from $1.37 to $-2.20 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#133 of 204 in Health CareTop 65% of 204This company -$2.20 Sector average -$0.89
▼
-148.2% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 136.6% year-over-year.
- Ranks #133 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.20 | -136.6% |
| FY2024 | -$0.93 | -167.9% |
| FY2023 | $1.37 | +213.2% |
| FY2022 | -$1.21 | -363.0% |
| FY2021 | $0.46 | +135.1% |
| FY2020 | -$1.31 | -59.8% |
| FY2019 | -$0.82 | -176.6% |
| FY2018 | $1.07 | +230.5% |
| FY2017 | -$0.82 | -176.6% |
| FY2016 | $1.07 | +337.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026